US 10611816
Anti-KRAS-G12D T cell receptors
granted A61KA61K38/00A61P
Quick answer
US patent 10611816 (Anti-KRAS-G12D T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00